KCT0008060招募中未知
Effect of Lythrum salicaria extract on body fat reduction; a randomized, double-blinded, placebo-controlled clinical trial
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 75(Year)（—）
- 性别
- All
入选标准
- •1. A person who consented to participate in this study and voluntarily signed a written consent form
- •2. Adult men and women between the ages of 19 and 75
- •3. A person with a body mass index(BMI) of 23 to 30 kg/m2
排除标准
- •1. Subjects with severe cerebrovascular disease(cerebral infarction, cerebral hemorrhage, etc.), heart disease(angina pectoris, myocardial infarction, heart failure, arrhythmia requiring treatment), or malignant tumor within the last 6 months
- •2. Patients with uncontrolled hypertension (blood pressure of 160/100mmHg or higher, measurement standard after subject resting for 10 minutes)
- •3. Diabetic patients with poor blood sugar control (fasting blood sugar of 160mg/dl or higher)
- •4. Those who are being treated for hypothyroidism or hyperthyroidism
- •5. A person whose creatinine measurement value is more than twice the upper limit of normal of the research institution
- •6. A person whose AST (GOT) or ALT (GPT) measurement value is more than 3 times the upper limit of normal of the research institution
- •7. Those who complain of severe gastrointestinal symptoms such as heartburn and indigestion (lactose intolerance)
- •8. A person who has been taking drugs that affect weight within the past month
- •9. Those who have participated in a commercial obesity program within the last 3 months
- •10. Those who have participated or plan to participate in other clinical trials within the last month
- •11. Alcohol Abuse
- •12. Non-smoking within 3 months
- •13. Those who are pregnant/lactating or plan to become pregnant during the human application test period
- •14. A person who has an allergic reaction to component foods
- •15. A person who is judged to be unsuitable by the tester for other reasons
研究者
相似试验
已完成
不适用
Anti-obesity effect of the plant extract in subjects with abdominal obesityHealthy volunteersJPRN-UMIN000020189Hiroshima University60
进行中（未招募）
不适用
Effect of liraglutide on body weight in obese subjects without diabetes. A 20-week randomised, double-blind, placebo-controlled, six armed parallel group, multi-centre, multinational trial with an open label orlistat comparator arm with an 84 week extension periodTrial Phase:2bMedDRA version: 9.0Level: PTClassification code 10012601obesityEUCTR2006-004481-13-BEovo Nordisk A/S
进行中（未招募）
不适用
Effect of liraglutide on body weight in obese subjects without diabetesA 20-week randomised, double-blind, placebo-controlled, six armed parallel group, multi-centre, multinational trial with an open label orlistat comparator armTrial Phase:2bMedDRA version: 9.0Level: PTClassification code 10012601obesityEUCTR2006-004481-13-NLovo Nordisk A/S547
进行中（未招募）
不适用
Effect of liraglutide on body weight in obese subjects without diabetes. A 20-week randomised, double-blind, placebo-controlled, six armed parallel group, multi-centre, multinational trial with an open label orlistat comparator arm with an 84 week extension periodTrial Phase:2bobesityEUCTR2006-004481-13-CZovo Nordisk A/S547
进行中（未招募）
不适用
Effect of liraglutide on body weight in obese subjects without diabetesA 20-week randomised, double-blind, placebo-controlled, six armed parallel group, multi-centre, multinational trial with an open label orlistat comparator armTrial Phase:2bMedDRA version: 9.0Level: PTClassification code 10012601obesityEUCTR2006-004481-13-SEovo Nordisk A/S547